Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
2.070
0.00 (0.00%)
May 19, 2025, 4:00 PM - Market open
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $89.46 million as of May 20, 2025. Its market cap has decreased by -86.19% in one year.
Market Cap
89.46M
Enterprise Value
-146.25M
1-Year Change
-86.19%
Ranking
Category
Stock Price
$2.07
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $89.46M, a decrease of -90.04%. That is a compound annual growth rate of -83.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2025 | 89.46M | -44.59% |
| Dec 31, 2024 | 161.46M | -82.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.89B |
| Johnson & Johnson | 366.90B |
| AbbVie | 328.04B |
| Novo Nordisk | 293.82B |
| UnitedHealth Group | 286.56B |
| Abbott Laboratories | 235.83B |
| Novartis AG | 215.48B |
| AstraZeneca | 214.95B |